| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 727843 | 1191388001 | POLIVY 140 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | POLIVY 140 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 140 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191388001/1191388001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191388001/1191388001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 29096 | ROCHE FARMA S.A. | 2020-02-18 | 1 | 1 | 1 | 2020-02-19 | 2020-02-18 | 1 | 2021-08-27 | View Edit Delete | ||||||||||||
| 729638 | 1191388002 | POLIVY 30 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | POLIVY 30 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 30 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191388002/1191388002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191388002/1191388002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 29096 | ROCHE FARMA S.A. | 2020-10-28 | 1 | 1 | 1 | 2020-10-29 | 2020-10-28 | 1 | 2021-08-27 | View Edit Delete | ||||||||||||
| 727061 | 1191389001 | EPIDYOLEX 100 MG/ML SOLUCION ORAL | EPIDYOLEX 100 MG/ML SOLUCION ORAL, 1 frasco de 100 ml | 100 mg/ml | 6 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191389001/1191389001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191389001/1191389001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 35481 | JAZZ PHARMACEUTICALS IBERIA S.L. | 2019-12-05 | 1 | 1 | 1 | 2019-12-06 | 2019-12-05 | 1 | 2021-08-03 | View Edit Delete | ||||||||||||
| 732440 | 1191390002 | INBRIJA 33 MG POLVO PARA INHALACION CAPSULAS DURAS | INBRIJA 33 MG POLVO PARA INHALACION CAPSULAS DURAS, 92 capsulas y 1 inhalador | 33 mg/dosis | 7 | 92 | 43 | 92 capsulas y 1 inhalador | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191390002/1191390002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191390002/1191390002_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39463 | ESTEVE PHARMACEUTICALS S.A. | 2021-12-21 | 1 | 1 | 1 | 2021-12-22 | 2021-12-21 | 1 | 2022-12-05 | View Edit Delete | ||||||||||||
| 731056 | 1191393001 | QUOFENIX 300 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | QUOFENIX 300 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 10 viales | 300 mg | 45 | 10 | 34 | 10 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191393001/1191393001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191393001/1191393001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 32477 | LABORATORIOS MENARINI S.A. | 2021-06-25 | 1 | 1 | 1 | 2021-06-26 | 2021-06-25 | 1 | 2022-11-29 | View Edit Delete | ||||||||||||
| 731057 | 1191393002 | QUOFENIX 450 mg COMPRIMIDOS | QUOFENIX 450 mg COMPRIMIDOS, 10 comprimidos | 450 mg | 5 | 10 | 10 | 10 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191393002/1191393002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191393002/1191393002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 32477 | LABORATORIOS MENARINI S.A. | 2021-06-25 | 1 | 1 | 1 | 2021-06-26 | 2021-06-25 | 1 | 2022-11-29 | View Edit Delete | ||||||||||||
| 728670 | 1191394002 | TIGECICLINA ACCORD 50 MG POLVO PARA SOLUCION PARA PERFUSION EFG | TIGECICLINA ACCORD 50 MG POLVO PARA SOLUCION PARA PERFUSION EFG, 10 viales | 50 mg | 45 | 10 | 34 | 10 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191394002/1191394002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191394002/1191394002_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2020-06-08 | 1 | 1 | 1 | 2020-06-09 | 2020-06-08 | 1 | 2022-11-14 | View Edit Delete | ||||||||||||
| 730482 | 1191397001 | BORTEZOMIB FRESENIUS KABI 3,5 MG POLVO PARA SOLUCION INYECTABLE EFG | BORTEZOMIB FRESENIUS KABI 3,5 MG POLVO PARA SOLUCION INYECTABLE EFG, 1 vial | 3,5 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191397001/1191397001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191397001/1191397001_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1097 | FRESENIUS KABI ESPAÑA, S.A.U. | 2021-02-26 | 1 | 1 | 1 | 2021-02-27 | 2021-02-26 | 1 | 2022-01-26 | View Edit Delete | ||||||||||||
| 727422 | 1191398003 | TRIOXIDO DE ARSENICO ACCORD 1 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | TRIOXIDO DE ARSENICO ACCORD 1 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 10 viales de 10 ml | 1 mg/ml inyectable 10 ml | 45 | 10 | 34 | 10 viales de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191398003/1191398003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191398003/1191398003_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2019-12-26 | 1 | 1 | 1 | 2019-12-27 | 2019-12-26 | 1 | 2020-04-22 | View Edit Delete | ||||||||||||
| 727277 | 1191399001 | XOSPATA 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | XOSPATA 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA 84 comprimidos | 40 mg | 5 | 84 | 10 | 84 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191399001/1191399001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191399001/1191399001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 13990 | ASTELLAS PHARMA S.A. | 2019-12-05 | 1 | 1 | 1 | 2019-12-06 | 2019-12-05 | 1 | 2023-05-12 | View Edit Delete | ||||||||||||
| 727711 | 1191404001 | RINVOQ 15 MG COMPRIMIDOS DE LIBERACION PROLONGADA | RINVOQ 15 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 28 comprimidos | 15 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191404001/1191404001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191404001/1191404001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 41086 | ABBVIE SPAIN, S.L.U. | 2020-01-28 | 1 | 1 | 1 | 2020-01-29 | 2020-01-28 | 1 | 2020-11-05 | View Edit Delete | ||||||||||||
| 731564 | 1191404006 | RINVOQ 30 MG COMPRIMIDOS DE LIBERACION PROLONGADA | RINVOQ 30 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191404006/1191404006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191404006/1191404006_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 41086 | ABBVIE SPAIN, S.L.U. | 2021-09-03 | 1 | 1 | 1 | 2021-09-04 | 2021-09-03 | 1 | 2022-03-07 | View Edit Delete | ||||||||||||
| 758539 | 1191404010 | RINVOQ 45 MG COMPRIMIDOS DE LIBERACION PROLONGADA | RINVOQ 45 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 28 comprimidos | 45 mg | 7 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191404010/1191404010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191404010/1191404010_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 41086 | ABBVIE SPAIN, S.L.U. | 2022-10-11 | 1 | 1 | 1 | 2022-10-12 | 2022-10-11 | 1 | 2023-11-14 | View Edit Delete | ||||||||||||
| 728672 | 1191405001 | TAVLESSE 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | TAVLESSE 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 60 comprimidos | 100 mg | 6 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1191405001/1191405001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191405001/1191405001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3896 | INSTITUTO GRIFOLS S.A. | 2020-06-03 | 1 | 1 | 1 | 2020-06-04 | 2020-06-03 | 1 | 2021-07-27 | View Edit Delete | ||||||||||||
| 728673 | 1191405002 | TAVLESSE 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | TAVLESSE 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 60 comprimidos | 150 mg | 6 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1191405002/1191405002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191405002/1191405002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3896 | INSTITUTO GRIFOLS S.A. | 2020-06-03 | 1 | 1 | 1 | 2020-06-04 | 2020-06-03 | 1 | 2021-07-27 | View Edit Delete | ||||||||||||
| 727646 | 1191406001 | BAQSIMI 3 MG POLVO NASAL EN ENVASE UNIDOSIS | BAQSIMI 3 MG POLVO NASAL EN ENVASE UNIDOSIS, 1 envase unidosis | 3 mg/dosis | 37 | 1 | 37 | 1 envase unidosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191406001/1191406001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191406001/1191406001_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16616 | AMPHASTAR FRANCE PHARMACEUTICALS | 2020-01-17 | 1 | 1 | 1 | 2020-01-18 | 2020-01-17 | 1 | 2020-12-11 | View Edit Delete | ||||||||||||
| 730221 | 1191407001 | ISTURISA 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ISTURISA 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 60 comprimidos | 1 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191407001/1191407001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191407001/1191407001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 68204 | RECORDATI RARE DISEASES SPAIN, S.L.U. | 2021-02-12 | 1 | 1 | 1 | 2021-02-13 | 2021-02-12 | 1 | 2022-05-09 | View Edit Delete | ||||||||||||
| 730264 | 1191407003 | ISTURISA 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ISTURISA 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 60 comprimidos | 10 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191407003/1191407003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191407003/1191407003_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 68204 | RECORDATI RARE DISEASES SPAIN, S.L.U. | 2021-02-12 | 1 | 1 | 1 | 2021-02-13 | 2021-02-12 | 1 | 2022-05-09 | View Edit Delete | ||||||||||||
| 730054 | 1191408002 | SUNOSI 75 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | SUNOSI 75 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 75 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191408002/1191408002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191408002/1191408002_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 35106 | JAZZ PHARMACEUTICALS IBERIA S.L. | 2021-02-12 | 1 | 1 | 1 | 2021-02-13 | 2021-02-12 | 0 | 2023-11-27 | View Edit Delete | ||||||||||||
| 730052 | 1191408007 | SUNOSI 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | SUNOSI 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 150 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191408007/1191408007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191408007/1191408007_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 35106 | JAZZ PHARMACEUTICALS IBERIA S.L. | 2021-02-12 | 1 | 1 | 1 | 2021-02-13 | 2021-02-12 | 0 | 2023-11-27 | View Edit Delete |
Page 103 of 1035, showing 20 records out of 20697 total, starting on record 2041, ending on 2060